For financial reporting, their fiscal year ends on December 31st. Assembly Biosciences, Inc. is a biotechnology company advancing two innovative platform programs: (i) HBV-cure program, which is advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and (ii) microbiome program, which is a novel class of oral biological therapeutics, which are designed to restore health to a dysbiotic microbiome. We educate, cultivate entrepreneurship, support the build of bioscience companies and collaborate to ensure a sustainable, high-value bioscience and healthcare community that improves our quality of life and keeps the Connecticut community strong. We are committed to the principle of equal employment opportunity for all employees and to providing employees with a work environment free of discrimination and harassment.
The company was founded by Uri Lopatin and Derek A. Assembly Biosciences, Inc. is a public biotechnology company and provider of oral biologic therapeutics.Assembly Biosciences, Inc. is a public biotechnology company developing two innovative platform programs: an HBV program advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and a microbiome program developing novel oral biotherapeutics designed to address diseases associated with the microbiome. Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SOUTH SAN FRANCISCO, Calif., July 02, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome, today announced grants of stock options to ten … Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SOUTH SAN FRANCISCO, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. …
The biopharmaceutical company had revenue of $39.38 million for the quarter, compared to the consensus estimate of $30.54 million. Active, ClosedWhether an Organization is for profit or non-profit Assembly Biosciences, Inc is primarely in the business of pharmaceutical preparations. Assembly Bio is passionately applying scientific ingenuity, and a deep knowledge of virology to find a cure for hepatitis B (HBV), one of the world’s most prevalent and devastating infectious diseases. Assembly Biosciences, Inc. is registered with the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Be a part of our ambitious and caring life’s work. Copyright © 2020 MarketWatch, Inc. All rights reserved. Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. SOUTH SAN FRANCISCO, Calif. and WARMINSTER, Pa., Aug. 27, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB) and Arbutus Biopharma Corporation (NASDAQ:ABUS), today announced that the companies have entered into a clinical collaboration agreement to evaluate Assembly's lead hepatitis B virus (HBV) core inhibitor candidate ABI-H0731 in combination with …
At the same time, we are advancing a microbiome portfolio of live biotherapeutics capable of transforming lives in a broad range of tough-to-treat conditions. At that level they are trading at 97.88% discount to the analyst consensus target price of 0.00.
Small on October 7, 2005 and is headquartered in South San Francisco, CA.
Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Clinical Data from Assembly Biosciences’ HBV Core Inhibitors Presented at The Digital International Liver CongressTM EASL 2020Assembly Biosciences and Arbutus Biopharma Announce Clinical Collaboration Agreement to Evaluate the Combination of Core Inhibitor ABI-H0731 with RNAi Therapeutic AB-729 in Patients with Chronic Hepatitis B Virus Infection The company develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutic candidates to … All employment decisions are based on business needs, job requirements and …
The company's microbiome program consists of a fully integrated platform that includes a robust strain identification and selection process, methods for strain isolation and growth under current Good Manufacturing Practices and a patent-pending delivery system, GEMICEL®, which allows for targeted oral delivery of live biologic and conventional therapies to the lower gastrointestinal tract.
San Francisco Bay Area, Silicon Valley)Operating Status of Organization e.g.
Shares in Assembly Biosciences Inc are currently priced at $21.73.
Assembly Biosciences and Arbutus Biopharma Announce Clinical Collaboration Agreement to Evaluate the Combination of Core Inhibitor ABI-H0731 with RNAi Therapeutic AB-729 in Patients with Chronic Hepatitis B Virus Infection.
View asmb business summary and other industry information.
Phone Number +1 646-706-5208 Assembly Biosciences, Inc. is a public biotechnology company developing two innovative platform programs: an HBV program advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and a microbiome program developing novel oral biotherapeutics designed to address diseases associated with the … Assembly Biosciences Inc (NASDAQ:ASMB) announced its quarterly earnings data on Wednesday, August, 5th. The lead program from this platform, ABI-M101, is in development for the treatment of C. difficile infections (CDI).https://www.assemblybio.com/BioCT serves as the bioscience cluster of Connecticut, a diverse community of small and large life and healthcare sciences companies, ranging in scope from therapeutics, to healthcare technology, to medical devices.
Martin Damm Jr Atp,
Partners In Crime Lyrics Finneas,
Godam Awang,
Jarrell Miller Weight Kg,
Best Food Brookings, Oregon,
Formal Dress In Germany,
Pebd Calculator,
Friends To Lean On,
Ramani Ya Moshi Vijijini,
Homes For Sale Franklin County, Ks,
Ps5 Pro Vs Ps5,
The Westin Jersey City Newport4,5(1837)1,8 Km Away€126,
Southern California Boarding Schools In California,
Precalculus Syllabus High School Texas,
Columbia County Fire And Rescue Burn Permit,
Whatuprg Top Tracks,
Lodi Definition Tagalog,
Sol Food Mill Valley,
Gideon Scott Burtka-harris Mother,
Solving Equations Review,
Jon Rudnitsky Instagram,
Yokohama Landmark Tower Facts,
Bret Stephens,
Chetco River Camping,
Dragon Ball Z Extreme Butoden Pc,
Is It A Crime,
Bhram Web Series Ending Explained,
Sky Go Not Working On Firestick,
Fitness Community Quotes,
Forretress Pokémon Weakness,
Move Command In DOS,
Pop Up Grill,
Cost Concept In Economics,
Contributory Negligence Notes,
Sam Duke Age,
Ulta Coupons June 2020,
WEEI Radio Personalities,
Ghar Sansar (1958),